Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and...
Pfizer has selected a preferred once-daily modified-release formulation for its weight loss candidate danuglipron, as the company looks to get ahead in the oral...
A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according to a study by Stanford University researchers.
Currently,...
Pfizer said on Wednesday that Canada's health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B...
The US Food and Drug Administration on Wednesday approved Pfizer's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against...
Pfizer's experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing severe infections in infants when given to expecting mothers in the second...
UK health regulator on Wednesday approved the country's first two-pronged COVID-19 booster targeting the Omicron BA.4 and BA.5 sub-variants and the original coronavirus strain.
The...
US drugmaker Pfizer and German partner BioNTech SE said on Friday their Omicron-tailored shot targeting the BA.4/5 subvariants produced a strong antibody response in...
The US Food and Drug Administration said on Friday it has granted full approval to Pfizer and BioNTech's COVID-19 vaccine for adolescents aged between...
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the...
US Food and Drug Administration staff reviewers on Sunday said Pfizer-BioNTech's COVID-19 vaccines were effective and safe for use in children aged 6 months...
Additional reports of patients with long COVID who were helped by Pfizer's oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to...